← Leaderboards
Joel S Karliner
Northern California Institute Res &Educ
$2,735,173
Attributed
$2,735,173
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$11,308,582 · 4
VA$0 · 2
By mechanism
P01$9,563,227 · 2
R01$1,745,355 · 2
I01$0 · 2
Top collaborators
- Mary C Nakamura4 shared
Most similar at Northern California Institute Res &Educ
Same institution · by research overlap
- Mary C Nakamura$3,345,292
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureCardiac MyocytesCongestive Heart FailureTraffickingPathway InteractionsReperfusion TherapyCoronary ArteriosclerosisCardiacLigationSignal TransductionMyocardial InfarctionMouse ModelAnterior Descending Coronary ArteryCellsAreaReperfusion InjuryCell TypeCoronaryVentricularInfarctionLeftIschemiaMyocardial Ischemia /HypoxiaInjury
Grant awards (18)
Immune Modulation and Cardiac Remodeling$0
I01 · FY2020 · VA
Immune Modulation and Cardiac Remodeling$0
I01 · FY2019 · VA
Immune Modulation and Cardiac Remodeling$0
I01 · FY2018 · VA
Immune Modulation and Cardiac Remodeling$0
I01 · FY2017 · VA
Sphingosine 1-phosphate and cardioprotection$383,625
R01 · FY2012 · HL · contact PI
Sphingosine 1-phosphate and cardioprotection$387,500
R01 · FY2011 · HL · contact PI
Sphingosine 1-phosphate and cardioprotection$387,500
R01 · FY2010 · HL · contact PI
Sphingosine 1-phosphate and cardioprotection$387,500
R01 · FY2009 · HL · contact PI
Prevention of heart failure and death by sphingolipids: outcomes and mechanisms.$0
I01 · FY2009 · VA · contact PI
Mechanisms of Cardioprotection in Ischemia and Failure$1,836,544
P01 · FY2006 · HL · contact PI
Lysophospholipids and gelsolin in cardioprotection$345,372
P01 · FY2006 · HL · contact PI
Mechanisms of Cardioprotection in Ischemia and Failure$1,828,528
P01 · FY2005 · HL
Lysophospholipids and gelsolin in cardioprotection$335,784
P01 · FY2005 · HL
Mechanisms of Cardioprotection in Ischemia and Failure$1,777,839
P01 · FY2004 · HL
Mechanisms of Cardioprotection in Ischemia and Failure$1,587,187
P01 · FY2003 · HL
Mechanisms of Cardioprotection in Ischemia and Failure$1,543,311
P01 · FY2002 · HL
Lysophospholipids and gelsolin in cardioprotection$308,662
P01 · FY2002 · HL
PROTECTION FROM CARDIAC REPERFUSION INJURY BY ETHANOL$199,230
R01 · FY2000 · AA